|
|
| MRD / Regn No. |
: MH/23-24/02760 |
Date |
: 01/06/2026 |
| Patient Name |
: ANANDHAN |
Age & Gender |
: 52 Yrs. / Male |
| Contact No. |
: 9585661330 |
UHID |
: |
| Ht / Wt / BMI |
: / 75 / |
BP S / BP D |
: 160 / 116 |
| Allergies |
: NO ALLERGIES |
Referred By |
: |
| |
|
| Problem
List |
: |
T2DM - UNCONTROLLED (01/Jun/2026) | HTN (01/Jun/2026) | |
|
Subjective |
: |
ASYMPTOMATIC |
| Salient Investigations |
: |
FASTING PLASMA GLUCOSE (FPG): 326 mg/dL | POST PRANDIAL GLUCOSE (2HPP): 412 100 | UREA: 27 mg/dL | CREATININE: 0.99 1 | EGFR EGLOMERULAR FILTRATION RATE: 84.46 mL/min/1.73m2 | URIC ACID: 3.8 | TOTAL CHOLESTEROL: 141 1 | HDL HIGH DENSITY LIPOPROTEIN: 38 mg/dL | TGL TRIGLYCERIDE: 167 mg/dL | LDL LOW DENSITY LIPOPROTEIN: 69.6 mg/dL | HBA1C GLYCOSYLATED HEMOGLOBIN: 10.6 mg/dL | TOTAL BILIRUBIN: 0.71 mg/dL | DIRECT BILURUBIN: 0.26 | INDIRECT BILURUBIN: 0.45 | ALBUMIN: 4.1 g/dL | GLOBULIN: 2.86 | |
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
TABLET GLIMEPRIDE 2 +METFORMIN 500 + VOGLIBOSE 0.2
GLIMIWINDAR TRIO 2 |
ORAL |
1-0-1 |
AFTER FOOD
|
TILL NEXT VISIT |
|
|
2 |
TABLET METAPROLOL 50+ TELMISARTAN 40 + CHLORTHALIDONE 6.25
METOSARTAN CH |
ORAL |
0-0-1 |
AFTER FOOD
|
TILL NEXT VISIT |
|
|
3 |
TABLET ROSUVASTATIN 5 MG
ROSUWIN 5
Medicine For CHOLESTROL/HEART |
ORAL |
0-0-1 |
AFTER FOOD
|
TILL NEXT VISIT |
|
|
4 |
TABLET EMPAGLIFLOZIN + LINAGLIPTIN
EMNORM-L |
|
1-0-0 |
AFTER FOOD
|
|
|
|
5 |
TABLET METHYLCOBALAMIN+ MINERALS+VITAMINS
RENEW BT
Medicine For GENE HEALTH |
ORAL |
1-0-0 |
AFTER FOOD
|
TILL NEXT VISIT |
|
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 28/Nov/2026 |
| Tests Suggested For Next Visit |
: |
| |
|
| |
|
